Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Cash flows from operating activities:
Net income	$ 10,458	$ 10,003
Adjustments to reconcile net income to net cash provided by operations:
Gain on divestitures	(500)	0
Depreciation and amortization	8,167	5,802
Stock-based compensation expense	1,720	1,185
Provision for deferred income taxes	3,207	2,917
Credit loss expense	29	6
Gain on sale of assets	(621)	(823)
Amortization of original issue discount and debt issuance costs	79	69
Change in assets and liabilities:
Increase in receivables	(3,068)	(10,015)
Decrease in inventories	2,159	5,088
Increase in other assets	(41)	(256)
Increase (decrease) in accounts payable	3,715	(522)
Decrease in accrued liabilities and other	(4,193)	(4,626)
Net cash provided by operating activities	21,111	8,828
Cash flows from investing activities:
Capital expenditures	(16,684)	(10,011)
Proceeds from divestitures	5,490	10,665
Proceeds from sale of property, plant and equipment	483	1,818
Other investing activities	0	2,946
Net cash provided by (used in) investing activities	(10,711)	5,418
Cash flows from financing activities:
Borrowings on lines of credit	12,100	0
Payments on lines of credit	(17,400)	0
Purchases of treasury stock	(2,683)	(10,810)
Proceeds from employee stock plans	491	0
Other financing activities	(1,428)	(865)
Net cash used in financing activities	(8,920)	(11,675)
Effect of exchange rate changes on cash	(83)	26
Net increase in cash, cash equivalents, and restricted cash	1,397	2,597
Cash, cash equivalents, and restricted cash at beginning of period	5,140	18,237
Cash, cash equivalents, and restricted cash at end of period	$ 6,537	$ 20,834